Characterization of the pathogenic autoreactive T cells in cyclosporine- induced syngeneic graft-versus-host disease

Journal of Immunology

Volumn 161, Issue 12, 1998, Pages 7040-7046

  Chen, Weiran ^a   Thoburn, Christopher ^a   Hess, Allan D ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; AUTOIMMUNITY; BONE MARROW TRANSPLANTATION; CYTOTOXIC T LYMPHOCYTE; DNA FLANKING REGION; DRUG INDUCED DISEASE; GENE DELETION; GENE EXPRESSION REGULATION; GRAFT VERSUS HOST REACTION; NONHUMAN; PRIORITY JOURNAL; RAT; SEQUENCE ANALYSIS; T LYMPHOCYTE ACTIVATION; TARGET CELL;

AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, DIFFERENTIATION, B-LYMPHOCYTE; AUTOIMMUNE DISEASES; AUTOIMMUNITY; BONE MARROW TRANSPLANTATION; CYCLOSPORINE; GENE REARRANGEMENT, ALPHA-CHAIN T-CELL ANTIGEN RECEPTOR; GENE REARRANGEMENT, BETA-CHAIN T-CELL ANTIGEN RECEPTOR; GRAFT VS HOST DISEASE; HISTOCOMPATIBILITY ANTIGENS; HISTOCOMPATIBILITY ANTIGENS CLASS II; INTERFERON TYPE II; INTERLEUKINS; LYMPHOKINES; MOLECULAR SEQUENCE DATA; POLYMERASE CHAIN REACTION; RATS; RATS, INBRED LEW; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEQUENCE ALIGNMENT; T-LYMPHOCYTES, CYTOTOXIC; TH1 CELLS;

EID: 0032534746     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Kahan, B. D. 1989. Cyclosporine. N. Engl. J. Med. 21:1725.
2. Jenkins, M. K., R. H. Schwartz, and D. M. Pardoll. 1988. Effects of cyclosporin A on T cell development and clonal deletion. Science 241:1655.
3. Urdahl, K. B., D. M. Pardoll, and M. K. Jenkins. 1994. Cyclosporin A inhibits positive selection and delays negative selection in α/β TCR transgenic mice. J. Immunol. 152:2853.
4. Glazier, A., P. J. Tutschka, E. R. Farmer, and G. W. Santos. 1983. Graft-versus-host disease in cyclosporin A treated rats after syngeneic and autologous bone marrow reconstitution. J. Exp. Med. 158:1.
5. Hess, A. D., and C. J. Thoburn. 1997. Immune-biology and immunotherapeutic implications of syngeneic/autologous graft-vs-host disease. Immunol. Rev. 157: 111.
6. Hess, A. D., L. Horwitz, W. E. Beschorner, and G. W. Santos. 1985. Development of graft-vs-host disease-like syndrome in cyclosporine-treated rats after syngeneic bone marrow transplantation. I. Development of cytotoxic T lymphocytes with apparent polyclonal anti-la specificity, including autoreactivity. J. Exp. Med. 161:718.
7. Hess, A. D., L. R. Horwitz, and M. K. Laulis. 1993. Cyclosporine induced syngeneic graft-vs-host disease: prevention of autoaggression by treatment with monoclonal antibodies to T lymphocyte cell surface determinants and to MHC class II antigens. Clin. Immunol. Immunopathol. 69:341.
8. Fischer, A. C., P. P. Ruvolo, R. Burt, L. R. Horwitz, E. C. Bright, J. M. Hess, W. E. Beschorner, and A. D. Hess. 1995. Characterization of the autoreactive T cell repertoire in cyclosporine-induced syngeneic graft-versus-host disease: a highly conserved repertoire mediates autoaggression. J. Immunol. 154:3713.
9. Hess, A. D., C. Thoburn, and L. Horwitz. 1998. Promiscuous recognition of major histocompatibility class II determinants in cyclosporine-induced syngeneic graft-versus-host disease. Transplantation 65:785.
10. Hess, A. D., E. C. Bright, C. Thoburn, G. B. Vogelsang, R. J. Jones, and M. J. Kennedy. 1997. Specificity of effector lymphocytes in autologous graft-vs-host disease: role of the major histocompatibility complex class II invariant chain peptide. Blood 89:2203.
11. Matzinger, P. 1991. The JAM test: a simple assay for DNA fragmentation and cell death. J. Immunol. Methods 145:185.
12. Freisewinkel, I. M., K. Schench, and N. Koch. 1993. The segment of the invariant chain that is critical for association with major histocompatibility complex class II molecules contains the sequence of a peptide eluted from class II polypeptides. Proc. Natl. Acad. Sci. USA 90:9703.
13. Fangmann, J., R. Dalchau, G. J. Sawyer, C. A. Priestley, and J. W. Fabre. 1992. T cell recognition of donor major histocompatibility complex class I peptides during allograft rejection. Eur. J. Immunol. 22:1525.
14. Gold, D. P., and D. Bellgrau. 1991. Identification of a limited T-cell receptor β-chain variable region repertoire associated with diabetes in the BB rat. Proc. Natl. Acad. Sci. USA 88:9888.
15. Hess, A., P. Ruvulo, A. Fischer, L. Horwitz, E. Bright, and C. Thoburn. 1997. Characterization of the Vα/Vβ autoreactive T-cell repertoire in syngeneic graft-vs-host disease. Transplant. Proc. 29:709.
16. Shirwan, H., M. Ohanjanian, G. Burcham, L. Makowaka, and D. V. Cramer. 1993. Structure and diversity of rat T cell receptor α-chain genes. J. Immunol. 150:2295.
17. Siegling, A., M. Lehmann, C. Platzer, F. Emmrich, and H.-D. Volk. 1994. A novel multispecific competitor fragment for quantitative PCR analysis of cytokine gene expression in rats. J. Immunol Methods 177:23.
18. Williams, C. B., E. P. Blankenhorn, K. E. Byrd, G. Levinson, and G. A. Gutman. 1991. Organization and nucleotide sequence of the rat T cell receptor β-chain complex. J. Immunol. 146:4406.
19. Ibrahim, S., D. V. Dawson, P. Van Trigt, and F. Sanfillippo. 1993. Differential infiltration by CD45RO and CD45RA subsets of T cells associated with human heart allograft rejection. Am. J. Pathol. 142:1794.
20. Beschorner, W. E., C. A. Shinn, A. C. Fischer, G. W. Santos, and A. Hess. 1988. Cyclosporine-induced pseudo GVHD in the early post-cyclosporine period. Transplantation 46(Suppl.):112S.
21. Beschorner, W. E., P. J. Tutschka, and G. W. Santos. 1982. Chronic GVHD in the rat chimera. I. Clinical presentation, hematology, histology, and immunopathology in the long term chimeras. Transplantation 33:393.
22. Volc-Platzer, B., K. Rappersberger, I. Mosberger, W. Hinterberger, W. Emminger-Schmidmeier, T. Radaszkiewicz, and K. Wolff. 1988. Sequential immunohistologic analysis of the skin following allogeneic bone marrow transplantation. J. Invest. Dermatol. 91:162.
23. Gold, D. P., C. D. Surh, K. S. Sellins, K. Schroder, J. Sprent, and D. B. Wilson. 1994. Rat T cell responses to superantigens. II. Allelic differences in Vβ 8.2 and Vβ 8.5 β chains determine responsiveness to staphylococcal enterotoxin B and mouse mammary tumor virus-encoded proteins. J. Exp. Med. 179:63.
24. Hess, A. D., C. Thoburn, E. Bright, and L. Horwitz. 1997. Specificity of effector mechanisms in syngeneic graft-vs-host disease: recognition of the MHC class II invariant chain peptide. Transplant. Proc. 29:725.
25. Beschorner, W. E., P. J. Tutschka, and G. W. Santos. 1982. Sequential morphology of GVHD in the rat radiation chimera. Clin. Immunol. Immunopathol. 22: 203.
26. Muczynski, K. A., S. K. Anderson, and D. Pious. 1998. Discoordinate surface expression of IFN-γ-induced HLA class II proteins in nonprofessional antigen-presenting cells with absence of DM and class II colocalization. J. Immunol. 160:3207.
27. Cresswell, P. 1996. Invariant chain structure and MHC class II function. Cell 84:505.
28. + Tc1 and Tc2 populations in graft-versus-leukemia effect and graft-versus-host disease. J. Immunol. 157:4811.
29. Parkman, R. 1985. Clonal analysis of murine graft-versus-host disease. I. Phenotypic and functional of T lymphocyte clones. J. Immunol. 136:3542.
30. Parkman, R. 1990. Clonal analysis of graft-vs-host disease. In Graft-vs-Host Disease. S. J. Burakoff, H. J. Deeg, J. Ferrara, and K. Atkinson, eds. Marcel Dekker, New York, p. 51.
31. + T lymphocyte subsets. J. Immunol. 145:526.
32. Hemmer, B., M. Vergelli, C. Pinilla, R. Houghten, and R. Martin. 1998. Probing degeneracy in T-cell recognition using peptide combinatorial libraries. Immunol. Today 19:163.
33. Threlkeld, S. C., P. A. Wentworth, S. A. Kalamo, B. M. Wilkes, D. J. Ruhl, E. Keogh, J. Sidney, S. Southwood, B. D. Walker, and A. Sette. 1997. Degenerate and promiscuous recognition by CTL of peptide presented by the MHC class I A3-like superfamily. J. Immunol. 159:1648.
34. Vergelli, M., B. Hemman, M. Kalbus, A. B. Vogt, N. Ling, P. Conlon, J. E. Coligan, H. McFarland, and R. Martin. 1997. Modification of peptide ligands enhancing T cell responsiveness implies large numbers of stimulatory ligands for autoreactive T cells. J. Immunol. 158:3746.
35. Ghosh, P., M. A. Maya, E. Mellins, and D. C. Wiley. 1995. The structure of an intermediate in class II MHC maturation: clip bound to HLA-DR3. Nature 378: 457.
36. Malcherek, G., V. Gnau, G. Jung, H. G. Rammensee, and A. Melms. 1995. Supermotifs enable natural invariant chain-derived peptides to interact with many major histocompatibility complex class II molecules. J. Exp. Med. 181:527.
37. Freisewinkel, I. M., K. Schneck, and N. Koch. 1993. The segment of the invariant chain that is critical for association with major histocompatibility complex class II molecules contains the sequence of a peptide eluted from class II polypeptides. Proc. Natl. Acad. Sci. USA 90:9703.
38. Vogt, A. B., L. J. Stern, C. Amshoff, B. Dobberstein, G. J. Hammerling, and H. Kropshofer. 1995. Interference of distinct invariant chain regions with super-antigen contact area and antigenic peptide binding groove of HLA-DR. J. Immunol. 155:4757.
39. Siebenkotben, I. M., C. Carotens, and N. Koch. 1998. Identification of a sequence that mediates promiscuous binding of invariant chain to MHC class II allotypes. J. Immunol. 160:3355.
40. Ericson, M. L., M. Sundstrom, D. M. Sansom, and D. J. Charron. 1994. Mutually exclusive binding of peptide and invariant chain to major histocompatibility complex class II antigens. J. Biol. Chem. 269:25538.
41. Hong, S. C., D. B. Sant'Angelo, B. N. Dietel, R. Medzhitov, S. T. Yoon, P. G. Waterbury, and C. A. Janeway, Jr. 1997. The orientation of a T cell receptor to its MHC class II: peptide ligands. J. Immunol. 159:4395.
42. Fu, Y., P. A. Villas, and E. P. Blankenhorn. 1991. Genetic control of rat T-cell response to Staphylococcus aureus enterotoxins. Immunology 75:484.
43. Deckhut, A. M., Y.-H. Chien, M. A. Blackman, and D. L. Woodland. 1994. Evidence for a functional interaction between the β-chain of MHC class II and the T cell receptor α-chain during recognition of a bacterial superantigen. J. Exp. Med. 180: 1921.